Changes of lipolytic enzymes cluster with insulin resistance syndrome

[1]  S. Eisenberg,et al.  Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[2]  S. Grundy,et al.  Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  M D Jensen,et al.  In vivo regulation of lipolysis in humans. , 1994, Journal of lipid research.

[4]  M. Taskinen,et al.  Regulation of Apolipoprotein A-I–Containing Lipoproteins in IDDM , 1993, Diabetes.

[5]  R. Krauss,et al.  LDL Subclass Phenotypes and the Insulin Resistance Syndrome in Women , 1993, Circulation.

[6]  S. Grundy,et al.  Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  R. Krauss,et al.  Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. , 1993, The Journal of clinical investigation.

[8]  G. Lewis,et al.  Effects of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals , 1993, Diabetes.

[9]  P. Gambert,et al.  Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  K. Frayn.  Insulin resistance and lipid metabolism , 1993 .

[11]  M. Laakso,et al.  How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.

[12]  B. Paulweber,et al.  Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. , 1993, The Journal of clinical investigation.

[13]  R. DeFronzo,et al.  The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM Parents , 1992, Diabetes.

[14]  M. Laakso,et al.  Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  S. Haffner,et al.  Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X) , 1992, Diabetes.

[16]  M. Taskinen,et al.  Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease. , 1992, Journal of lipid research.

[17]  S. Coppack,et al.  Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. , 1992, Metabolism: clinical and experimental.

[18]  P. Wilson,et al.  Low density lipoprotein particle size and coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  H. Lithell,et al.  Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  D. Johnston,et al.  The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[21]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[22]  M. Taskinen.  3 Hyperlipidaemia in diabetes , 1990 .

[23]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[24]  J. Fruchart,et al.  Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. , 1990, Clinical chemistry.

[25]  R. James,et al.  Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. , 1990, Atherosclerosis.

[26]  J. Sparks,et al.  Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. , 1990, The Journal of biological chemistry.

[27]  G. Gibbons.  Assembly and secretion of hepatic very-low-density lipoprotein. , 1990, The Biochemical journal.

[28]  P. Kern,et al.  The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans. , 1990, The New England journal of medicine.

[29]  I. Goldberg,et al.  Interaction of lipoprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. , 1990, Biochimica et biophysica acta.

[30]  B. Bihain,et al.  Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[32]  G. Reaven,et al.  Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. , 1989, The Journal of clinical endocrinology and metabolism.

[33]  P. Kern,et al.  Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. , 1989, The Journal of clinical investigation.

[34]  R. Eckel,et al.  Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. , 1989, The New England journal of medicine.

[35]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[36]  P. Raskin,et al.  Relationship between lipoprotein levels and in vivo insulin action in normal young white men. , 1988, Metabolism: clinical and experimental.

[37]  M. Taskinen,et al.  Interrelationships Among Insulin's Antilipolytic and Glucoregulatory Effects and Plasma Triglycerides in Nondiabetic and Diabetic Patients With Endogenous Hypertriglyceridemia , 1988, Diabetes.

[38]  M. Taskinen,et al.  Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes , 1988, Arteriosclerosis.

[39]  S. Lillioja,et al.  Relationships Between Plasma Lipoprotein Concentrations and Insulin Action in an Obese Hyperinsulinemic Population , 1987, Diabetes.

[40]  A. Gotto,et al.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. , 1987, The Journal of clinical investigation.

[41]  M. Taskinen,et al.  7 Enzymes involved in triglyceride hydrolysis , 1987 .

[42]  K. Jen,et al.  Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus. , 1987, The Journal of clinical endocrinology and metabolism.

[43]  A. Golay,et al.  Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. , 1986, The Journal of clinical endocrinology and metabolism.

[44]  R. Eckel,et al.  Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity. , 1984, The Journal of clinical endocrinology and metabolism.

[45]  S. Eisenberg,et al.  Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.

[46]  L H Kuller,et al.  Plasma insulin and lipoprotein concentrations: an atherogenic association? , 1983, American journal of epidemiology.

[47]  D. Galton,et al.  Insulin-independent diabetes: A defect in the activity of lipoprotein lipase in adipose tissue , 1979, Diabetologia.

[48]  J. Brunzell,et al.  Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. , 1975, The Journal of clinical investigation.

[49]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[50]  G. Reaven,et al.  Role of insulin in endogenous hypertriglyceridemia. , 1967, The Journal of clinical investigation.

[51]  J. Margolis,et al.  Electrophoresis in polyacrylamide concentration gradient. , 1967, Biochemical and biophysical research communications.

[52]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[53]  C. Bouchard,et al.  Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[54]  L. Groop,et al.  The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. , 1991, The Journal of clinical endocrinology and metabolism.